These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2080010)

  • 41. Erythropoietin in the 90s. International Symposium, Würzburg, March 23-24, 1990.
    Contrib Nephrol; 1990; 87():1-114. PubMed ID: 1982712
    [No Abstract]   [Full Text] [Related]  

  • 42. Effect of angiotensin-converting enzyme inhibitors on anemia in hemodialyzed patients.
    Teruel JL; Fernandez Juarez G; Marcen R; Nogueira J; Ortuño J
    Nephron; 1996; 73(1):113. PubMed ID: 8742977
    [No Abstract]   [Full Text] [Related]  

  • 43. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 44. Haemoglobin concentrations in chronic kidney disease.
    Steinbrook R
    Lancet; 2006 Dec; 368(9554):2191-3. PubMed ID: 17189015
    [No Abstract]   [Full Text] [Related]  

  • 45. Successful trial of steroids in two haemodialysis patients with inflammatory disease and anaemia unresponsive to recombinant erythropoietin.
    Tzanakis I; Markidou F; Tzimis L; Kartsonakis V; Mamali V; Xini K; Kallivretakis N
    Nephrol Dial Transplant; 1996 Feb; 11(2):400-1. PubMed ID: 8700375
    [No Abstract]   [Full Text] [Related]  

  • 46. Use of recombinant human erythropoietin (rh-EPO) in the treatment of anemia in hemodialysis patients: a multicenter Italian experience.
    Buccianti G; Colombi L; Battistel V
    Haematologica; 1993; 78(2):111-7. PubMed ID: 8349186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desferrioxamine versus erythropoietin for treatment of dialysis anaemia.
    Padovese P; Gallieni M; Galmozzi C; Brancaccio D
    Lancet; 1990 Jun; 335(8703):1465. PubMed ID: 1972238
    [No Abstract]   [Full Text] [Related]  

  • 48. Erythropoietin--trials then tribulation.
    Stewart WK
    Scott Med J; 1991 Feb; 36(1):3-4. PubMed ID: 1903215
    [No Abstract]   [Full Text] [Related]  

  • 49. Improvement of anemia and secondary hyperparathyroidism with erythropoietin treatment in hemodialysis patients.
    Seyrek N; Paydas S; Sagliker Y
    Nephron; 1996; 73(2):338-9. PubMed ID: 8773378
    [No Abstract]   [Full Text] [Related]  

  • 50. [Chronic kidney failure, anemia and erythropoietin].
    Sulková S
    Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment.
    Yabana M; Ikeda Y; Kihara M; Kurita K; Toya Y; Tamura K; Takagi N; Onishi T; Umemura S
    Nephron; 1999 Jan; 81(1):111-2. PubMed ID: 9884433
    [No Abstract]   [Full Text] [Related]  

  • 52. Recombinant human erythropoietin and peritoneal dialysis.
    Digenis GE; Yatzidis H
    Int J Artif Organs; 1990 Jun; 13(6):344-6. PubMed ID: 2199378
    [No Abstract]   [Full Text] [Related]  

  • 53. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute effect of erythropoietin on endothelin release in uremia.
    Nurol A; Bahattin A; Tolga K; Tekin A; Abdülkerim B
    Nephron; 1996; 72(4):728-9. PubMed ID: 8730461
    [No Abstract]   [Full Text] [Related]  

  • 55. [Countermeasure for patients with anemia due to hemodialysis].
    Suzuki M
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1663-7. PubMed ID: 8537721
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant human erythropoietin therapy and autonomic nervous system.
    Suwata J; Maeda H; Ohmori N; Ohwa M; Ohtsuka H; Shimoyama H
    Nephron; 1992; 61(1):115-6. PubMed ID: 1528332
    [No Abstract]   [Full Text] [Related]  

  • 57. [Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients?].
    Sulková S; Laurincová Z; Kvasnicka J
    Cas Lek Cesk; 1990 Jan; 129(4):113-5. PubMed ID: 2331725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of recombinant human erythropoietin therapy on left ventricular hypertrophy in hemodialysis patients.
    Lezaić V; Vujisić B; Djukanović L; Simin N; Veljović R
    Clin Nephrol; 1992 Sep; 38(3):174-6. PubMed ID: 1395176
    [No Abstract]   [Full Text] [Related]  

  • 59. Epoetin dosing and dialysis facility ownership.
    Kliger AS; Nissenson AR
    JAMA; 2007 Aug; 298(8):861-2; author reply 862-3. PubMed ID: 17712067
    [No Abstract]   [Full Text] [Related]  

  • 60. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.